Delivery Order SPE2DX15D3003-SPE2DX24F5P3S
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$9.9K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $44,580.11 and a completion date of June 27, 2025. The contract provides for the delivery of Kisqali 600 mg daily dose 63s, a prescription medication. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $20,581.60 firm-fixed price contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty medication. This is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $62,118.53 delivery order is for the pharmaceutical product KISQALI 600 MG DAILY DOSE 63S, with an ultimate completion date of August 2, 2024. The contract type is firm fixed price. This award is not set aside for a particular business type. AmerisourceBergen, a major pharmaceutical...
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corporation for $17,752.54 to provide KISQALI 600 mg daily dose pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure essential medical commodities, including specialty, brand name, generic, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,631.72, is for the supply of KISQALI 200 MG DAILY DOSE medication. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $42,425.20, is for the supply of the brand name medication Kisqali 600 mg daily dose 63s. The delivery order has a performance period through March 11, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical...
This is a $21,620.88 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide KISQALI 400 MG DAILY DOSE 42S, a specialized medication. The contract has a period of performance through September 10, 2024 and utilizes a firm fixed price pricing structure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $54,081.28 firm fixed price contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a medication, with a performance period through May 27, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order federal contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Kisqali 600 mg daily dose medication, with a ceiling value of $93,103.45 and a period of performance through June 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Kisqali 600 mg daily dose 63s, a pharmaceutical product, with a ceiling value of $83,204.74 and a completion date of July 10, 2025. The contract is a firm fixed-price delivery order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...